Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519356) titled 'A Comprehensive Register Of Lymphoproliferative Disorders (ReLy)' on April 2.

Study Type: Observational [Patient Registry]

Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Condition: Lymphoproliferative Disease

Recruitment Status: Recruiting

Date of First Enrollment: June 9, 2022

Target Sample Size: 9000

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07519356

Published by HT Digital Content Services with permission from Health Daily Digest....